» Articles » PMID: 24304897

Plasma Proteome Database As a Resource for Proteomics Research: 2014 Update

Abstract

Plasma Proteome Database (PPD; http://www.plasmaproteomedatabase.org/) was initially described in the year 2005 as a part of Human Proteome Organization's (HUPO's) pilot initiative on Human Plasma Proteome Project. Since then, improvements in proteomic technologies and increased throughput have led to identification of a large number of novel plasma proteins. To keep up with this increase in data, we have significantly enriched the proteomic information in PPD. This database currently contains information on 10,546 proteins detected in serum/plasma of which 3784 have been reported in two or more studies. The latest version of the database also incorporates mass spectrometry-derived data including experimentally verified proteotypic peptides used for multiple reaction monitoring assays. Other novel features include published plasma/serum concentrations for 1278 proteins along with a separate category of plasma-derived extracellular vesicle proteins. As plasma proteins have become a major thrust in the field of biomarkers, we have enabled a batch-based query designated Plasma Proteome Explorer, which will permit the users in screening a list of proteins or peptides against known plasma proteins to assess novelty of their data set. We believe that PPD will facilitate both clinical and basic research by serving as a comprehensive reference of plasma proteins in humans and accelerate biomarker discovery and translation efforts.

Citing Articles

Establishing age-group specific reference intervals of human salivary proteome and its preliminary application for epilepsy diagnosis.

Xue N, Xia X, Wang Y, Li X, Zheng N, Wang Y Sci China Life Sci. 2024; 68(3):809-824.

PMID: 39731663 DOI: 10.1007/s11427-024-2730-6.


Reproductomics: Exploring the Applications and Advancements of Computational Tools.

SENGUPTA P, Dutta S, Liew F, Samrot A, Dasgupta S, Rajput M Physiol Res. 2024; 73(5):687-702.

PMID: 39530905 PMC: 11629954. DOI: 10.33549/physiolres.935389.


In Silico Modeling of Fabry Disease Pathophysiology for the Identification of Early Cellular Damage Biomarker Candidates.

Gervas-Arruga J, Barba-Romero M, Fernandez-Martin J, Gomez-Cerezo J, Segu-Verges C, Ronzoni G Int J Mol Sci. 2024; 25(19).

PMID: 39408658 PMC: 11477023. DOI: 10.3390/ijms251910329.


Integrative proteomic and metabolomic elucidation of cardiomyopathy with in vivo and in vitro models and clinical samples.

Hu Y, Zou Y, Qiao L, Lin L Mol Ther. 2024; 32(10):3288-3312.

PMID: 39233439 PMC: 11489546. DOI: 10.1016/j.ymthe.2024.08.030.


Machine Learning-Driven Biomarker Discovery for Skeletal Complications in Type 1 Gaucher Disease Patients.

Cebolla J, Giraldo P, Gomez J, Montoto C, Gervas-Arruga J Int J Mol Sci. 2024; 25(16).

PMID: 39201273 PMC: 11354847. DOI: 10.3390/ijms25168586.


References
1.
Shao H, Chung J, Balaj L, Charest A, Bigner D, Carter B . Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat Med. 2012; 18(12):1835-40. PMC: 3518564. DOI: 10.1038/nm.2994. View

2.
Kalra H, Simpson R, Ji H, Aikawa E, Altevogt P, Askenase P . Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 2012; 10(12):e1001450. PMC: 3525526. DOI: 10.1371/journal.pbio.1001450. View

3.
Li S, Peng M, Li H, Liu B, Wang C, Wu J . Sys-BodyFluid: a systematical database for human body fluid proteome research. Nucleic Acids Res. 2008; 37(Database issue):D907-12. PMC: 2686600. DOI: 10.1093/nar/gkn849. View

4.
Wang B, Huang H, Chen Y, Bristow R, Kassauei K, Cheng C . Increased plasma DNA integrity in cancer patients. Cancer Res. 2003; 63(14):3966-8. View

5.
Zhang H, Liu A, Loriaux P, Wollscheid B, Zhou Y, Watts J . Mass spectrometric detection of tissue proteins in plasma. Mol Cell Proteomics. 2006; 6(1):64-71. DOI: 10.1074/mcp.M600160-MCP200. View